X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
1. 1-(2-(2,4-dimethylphenylsulfanyl)phenyl)piperazine
2. Brintellix
3. Lu Aa21004
4. Lu-aa21004
5. Luaa21004
6. Vortioxetine
1. 960203-27-4
2. Vortioxetine Hbr
3. Brintellix
4. Vortioxetine (lu Aa21004) Hbr
5. Trintellix
6. Vortioxetine (hydrobromide)
7. Unii-tks641koay
8. Lu Aa 21004 Hydrobromide
9. Vortioxetine Hydrobromide [usan]
10. Lu Aa21004 Hbr
11. Tks641koay
12. Lu-aa21004 Hydrobromide
13. Lu Aa21004 (hbr)
14. 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine Hydrobromide
15. 960203-27-4 (hbr)
16. Chebi:76015
17. 1-(2-((2,4-dimethylphenyl)sulfanyl)phenyl)piperazine Monohydrobromide
18. Brintellix (tn)
19. 1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine Hydrobromide
20. 1-[2-[(2,4-dimethylphenyl)thio]phenyl]piperazine Hydrobromide
21. Piperazine, 1-(2-((2,4-dimethylphenyl)thio)phenyl)-, Hydrobromide (1:1)
22. Trintellix (tn)
23. Voltiocetin Hydrobromide
24. Lu Aa21004 Hydrobromide
25. Vortioxetine Monohydrobromide
26. Schembl237653
27. Lu-aa21004 Hbr
28. Chembl2107387
29. Lu-aa-21004
30. Dtxsid501027850
31. Amy25254
32. Bcp09588
33. Ex-a2348
34. Hy-15414a
35. Mfcd22383961
36. S8021
37. Vortioxetine Hydrobromide (jan/usan)
38. Akos016340374
39. Ccg-268394
40. Cs-1472
41. Hg-0011
42. Sb16507
43. Vortioxetine Hydrobromide [jan]
44. Ac-28325
45. Vortioxetine (lu Aa21004) Hydrobromide
46. Vortioxetine Hydrobromide [who-dd]
47. 960203-27-4, Trintellix, Brintellix,
48. Ft-0696676
49. Sw219360-1
50. D10185
51. Vortioxetine Hydrobromide [orange Book]
52. A855301
53. Lu Aa 21004 Hydrobromide;lu Aa21004 Hydrobromide
54. Q27145682
55. 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine-hbr
56. 1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine;hydrobromide
57. 1-[2-[(2,4-dimethylphenyl)thio]phenyl]-piperazine Hydrobromide
58. 1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine Hydrobromide
59. 4-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine Hydrobromide
60. 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium Bromide
1. Vortioxetine
| Molecular Weight | 379.4 g/mol |
|---|---|
| Molecular Formula | C18H23BrN2S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 378.07653 g/mol |
| Monoisotopic Mass | 378.07653 g/mol |
| Topological Polar Surface Area | 40.6 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 316 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Brintellix |
| PubMed Health | Meclizine, Buclizine, and Cyclizine (Oral route, Parenteral route) |
| Drug Label | BRINTELLIX is an immediate-release tablet for oral administration that contains the beta () polymorph of vortioxetine hydrobromide (HBr), an antidepreant. Vortioxetine HBr is known chemically as 1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]-piperazi... |
| Active Ingredient | Vortioxetine hydrobromide |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 15mg base; eq 5mg base; eq 20mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Takeda Pharms Usa |
| 2 of 2 | |
|---|---|
| Drug Name | Brintellix |
| PubMed Health | Meclizine, Buclizine, and Cyclizine (Oral route, Parenteral route) |
| Drug Label | BRINTELLIX is an immediate-release tablet for oral administration that contains the beta () polymorph of vortioxetine hydrobromide (HBr), an antidepreant. Vortioxetine HBr is known chemically as 1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]-piperazi... |
| Active Ingredient | Vortioxetine hydrobromide |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 15mg base; eq 5mg base; eq 20mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Takeda Pharms Usa |
Treatment of major depressive episodes in adults.
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
Serotonin 5-HT1 Receptor Agonists
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)
Serotonin 5-HT3 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)
N06AX26
Market Place
